KALA BIO , Inc. (NASDAQ: KALA) (“KALA BIO” or the “Company”), today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the “common stock”) at a ...
Shares of Bio-Techne Corp. plunged 16.36% to $47.41 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.46% to 7,365.12 and the ...
Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...
Climb Bio Inc. (NASDAQ:CLYM) is a clinical-stage biotech company focused on developing therapies for immune-mediated diseases ...
Shares of INmune Bio (NASDAQ:INMB) fell over 14% premarket on Friday after the immunology company launched a $13M securities offering. The firm entered into securities purchase agreements for the ...
Bluebird Bio has launched three gene-editing therapies. These treatments are expensive and complex to administer, and they face stiff competition. Though Bluebird Bio is an innovative biotech, the ...
Zacks Investment Research on MSN
Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to Trade
Q32 Bio (QTTB) closed the last trading session at $5.44, gaining 10.6% over the past four weeks, but there could be plenty of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Annovis Bio plans to move ...
Shares of Nuvation Bio (NYSE: NUVB) were skyrocketing 15.7% higher as of 11:20 a.m. ET on Tuesday. The big jump came after two positive developments for the cancer-focused drugmaker. Which news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results